43857-0804 NDC - LYMPH TONIC III (ADENOSINUM TRIPHOSPHORICUM DINATRUM, ARNICA MONTANA, BOLDO, CALCAREA IODATA, CALCAREA PHOSPHORICA, CARCINOSIN, ECHINACEA (ANGUSTIFOLIA), GERMANIUM SESQUIOXIDE, HAMAMELIS VIRGINIANA, HEPAR SULPHURIS CALCAREUM, INFLUENZINUM (2024-2025), NAJA TRIPUDIANS, NATRUM SULPHURICUM, PHYTOLACCA DECANDRA, PINUS SYLVESTRIS, PYROGENIUM, SULPHUR, THYROIDINUM (SUIS), UBIDECARENONUM)

Drug Information

  • Product NDC: 43857-0804
  • Proprietary Name: Lymph Tonic III
  • Non Proprietary Name: Adenosinum Triphosphoricum Dinatrum, Arnica Montana, Boldo, Calcarea Iodata, Calcarea Phosphorica, Carcinosin, Echinacea (Angustifolia), Germanium Sesquioxide, Hamamelis Virginiana, Hepar Sulphuris Calcareum, Influenzinum (2024-2025), Naja Tripudians, Natrum Sulphuricum, Phytolacca Decandra, Pinus Sylvestris, Pyrogenium, Sulphur, Thyroidinum (Suis), Ubidecarenonum
  • Active Ingredient(s): 12 [hp_X]/mL ADENOSINE TRIPHOSPHATE DISODIUM; 12 [hp_X]/mL ARNICA MONTANA WHOLE; 12 [hp_X]/mL CALCIUM IODIDE; 12 [hp_X]/mL CALCIUM SULFIDE; 1 [hp_X]/mL ECHINACEA ANGUSTIFOLIA WHOLE; 8 [hp_X]/mL GERMANIUM SESQUIOXIDE; 12 [hp_X]/mL HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; 200 [hp_X]/mL HUMAN BREAST TUMOR CELL; 30 [hp_C]/mL INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); 30 [hp_C]/mL INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); 30 [hp_C]/mL INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; 30 [hp_C]/mL INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE; 15 [hp_X]/mL NAJA NAJA VENOM; 3 [hp_X]/mL PEUMUS BOLDUS LEAF; 4 [hp_X]/mL PHYTOLACCA AMERICANA ROOT; 6 [hp_X]/mL PINUS SYLVESTRIS LEAFY TWIG; 30 [hp_X]/mL RANCID BEEF; 30 [hp_X]/mL SODIUM SULFATE; 30 [hp_X]/mL SULFUR; 6 [hp_X]/mL THYROID; 30 [hp_X]/mL TRIBASIC CALCIUM PHOSPHATE; 12 [hp_X]/mL UBIDECARENONE
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Blood Coagulation Factor [EPC]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calcium [CS]; Cations; Divalent [CS]; Cations; Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Coagulation Factor Activity [PE]; Phosphate Binder [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Phosphate Chelating Activity [MoA]

Labeler Information

Field Name Field Value
Labeler Name: BioActive Nutritional, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:3/18/2026

Package Information

No. Package Code Package Description Billing Unit
143857-0804-160 mL in 1 BOTTLE, DROPPER (43857-0804-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC43857-0804The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMELymph Tonic IIIThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAdenosinum Triphosphoricum Dinatrum, Arnica Montana, Boldo, Calcarea Iodata, Calcarea Phosphorica, Carcinosin, Echinacea (Angustifolia), Germanium Sesquioxide, Hamamelis Virginiana, Hepar Sulphuris Calcareum, Influenzinum (2024-2025), Naja Tripudians, Natrum Sulphuricum, Phytolacca Decandra, Pinus Sylvestris, Pyrogenium, Sulphur, Thyroidinum (Suis), UbidecarenonumThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE3/18/2026This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEBioActive Nutritional, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEADENOSINE TRIPHOSPHATE DISODIUM; ARNICA MONTANA WHOLE; CALCIUM IODIDE; CALCIUM SULFIDE; ECHINACEA ANGUSTIFOLIA WHOLE; GERMANIUM SESQUIOXIDE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HUMAN BREAST TUMOR CELL; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE; NAJA NAJA VENOM; PEUMUS BOLDUS LEAF; PHYTOLACCA AMERICANA ROOT; PINUS SYLVESTRIS LEAFY TWIG; RANCID BEEF; SODIUM SULFATE; SULFUR; THYROID; TRIBASIC CALCIUM PHOSPHATE; UBIDECARENONEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH12; 12; 12; 12; 1; 8; 12; 200; 30; 30; 30; 30; 15; 3; 4; 6; 30; 30; 30; 6; 30; 12 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESBlood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Cations, Divalent [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 5/7/2026

Previous Code
Next Code